News 2004

Crionna Assist US Biotech in Development of Phase III Strategic Development Plan for Oncology Product

 21 February Newly established CRO Crionna has been awarded a contract to assist in the design of three clinical trials as part of a Strategic Development Plan for a Phase III Oncology product. The US Biotechnology Company intends to launch the studies in both the US and Europe in 2005 following review and approval of the Phase III development plans by the FDA.

Crionna team members have, over a period of three years working with this company, sucessfully demonstrated their ability to harmonise study designs and identify cost effective modifications to study objectives leading to a significant reduction in timeframes and patient recruitment requirements.

This study will launch Crionna as a high level CRO and Clinical Trial Consultancy and allow the company to continue their pursuit of excellence in Oncology and Immunology focussed clinical trials.


Crionna Opens Offices at the West of Scotland Science Park

13 March Crionna Research Organisation, opened offices today at the West of Scotland Science Park in Glasgow. The company will use this base close to the famous Beatson Oncology centre to set up clinical trial management and advisory services for both the Biopharmaceutical and public health sector industries.

Crionna aims to assist both commercial and non commercial groups to conduct quality research and speed new therapies to patients. The company will focus on novel clinical products and utilise the scientific experience of the management team in Immunology and Oncology.

In addition to Clinical Trial Services, Crionna will continue to conduct a number of research projects including scientific research into Oral Cancer Gene expression and the development of novel electronic data capture and transfer systems. Over the coming years Crionna hopes to develop alliances with other specialist companies in these fields of Research and Development and to continue to address the unmet needs of patients.

Crionna Assist Local Pharmaceutical Company in Data Collection for UK Cancer Study

20 September Newly established Crionna today won business from a Scotland based pharmaceutical company to assist in data collection from patients receiving a photodynamic and chemotherapy combination. The data will be used as part of a portfolio of work to be presented to the FDA for a Go-No-Go decision on further clinical trials with this combination therapy.